Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.
Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.
MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.
Mylight150 create of a society in which people generates own electricity to ensure self-sufficiency and long-term abundance.
Qualisteo, a start-up company based in Nice specialised in smart grids company.
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
SoniVie Ltd develops an advanced denervation solution
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
INNOVO by Atlantic Therapeutics is a medical technology firm that develops pelvic floor muscle strengthening and nerve stimulation products.
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solution.
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
Sapiens is a medical device company that delivers solutions for deep brain stimulation therapy.
Andera Partners has invested in 65 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Andera Partners's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Genetics. The firm invests across 20 different industry categories.
Among tracked funding rounds, Amolyt Pharma received $138.6M in a Series C round. Andera Partners's total known invested capital is $5.3B.
Andera Partners's average investment size is $81.9M across its portfolio of 65 companies.
Recent Andera Partners portfolio additions include SciRhom, Nouscom, MMI, mylight150, Qualisteo. These companies were founded in 2020 or later.